The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 29,386,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 3,335,668 | 1,126,915 | SH | SOLE | 1,126,915 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 36,059,544 | 500,827 | SH | SOLE | 500,827 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 28,767,069 | 118,383 | SH | SOLE | 118,383 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 24,800,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 38,535,035 | 182,960 | SH | SOLE | 182,960 | 0 | 0 | ||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | 27,825,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
ASML HOLDING N V | N Y REGISTRY SHS | N07059210 | 136,366,727 | 133,336 | SH | SOLE | 133,336 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 40,341,700 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 18,861,500 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
BROOKFIELD ASSET MANAGMT LTD | CL A LMT VTG SHS | 113004105 | 23,865,226 | 627,207 | SH | SOLE | 627,207 | 0 | 0 | ||
BROOKFIELD CORP | CL A LTD VT SH | 11271J107 | 161,184,754 | 3,880,230 | SH | SOLE | 3,880,230 | 0 | 0 | ||
CABLE ONE INC | COM | 12685J105 | 41,914,662 | 118,403 | SH | SOLE | 118,403 | 0 | 0 | ||
CARGO THERAPEUTICS INC | COM | 14179K101 | 25,352,480 | 1,544,000 | SH | SOLE | 1,544,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 31,458,500 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 78,345,151 | 2,411,362 | SH | SOLE | 2,411,362 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 44,790,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 114,263,184 | 6,344,430 | SH | SOLE | 6,344,430 | 0 | 0 | ||
GALECTO INC | COM | 36322Q107 | 1,183,953 | 2,497,791 | SH | SOLE | 2,497,791 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 53,600,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | 5,182,455 | 4,429,449 | SH | SOLE | 4,429,449 | 0 | 0 | ||
KYVERNA THERAPEUTICS INC | COM | 501976104 | 13,125,000 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
LANZATECH GLOBAL INC | COM | 51655R101 | 29,257,463 | 15,814,845 | SH | SOLE | 15,814,845 | 0 | 0 | ||
LEXEO THERAPEUTICS INC | COM | 52886X107 | 23,266,020 | 1,450,500 | SH | SOLE | 1,450,500 | 0 | 0 | ||
MARQETA INC | CLASS A COM | 57142B104 | 2,419,738 | 441,558 | SH | SOLE | 441,558 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 39,939,750 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
METAGENOMI INC | COM | 59102M104 | 7,344,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 51,285,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 12,776,250 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 32,430,000 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 23,683,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
SALESFORCE INC | COM | 79466L302 | 123,449,136 | 480,160 | SH | SOLE | 480,160 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 609,573 | 468,902 | SH | SOLE | 468,902 | 0 | 0 | ||
TEMPUS AI INC | CL A | 88023B103 | 142,604,665 | 4,074,419 | SH | SOLE | 4,074,419 | 0 | 0 | ||
VANGUARD INDEX FDS | TOTAL STK MKT | 922908769 | 277,822,510 | 1,038,550 | SH | SOLE | 1,038,550 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 71,734,500 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 11,712,000 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 26,020,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 |